Facts & Figures

BioNTech is a privately held Company and has received funding from the Strüngmann Family Office and the MIG Fonds (Munich) in one of the largest initial financing rounds ever in the European biotech sector.

Management

Prof. Dr. Ugur Sahin
Sean Marett
Dr. Sierk Poetting

Employees

450 (July 2016)

Headquarters

Mainz, Germany

Founding Year

2008

Founded By

Prof. Dr. Ugur Sahin
Prof. Dr. Christoph Huber
as Spin-off of
Johannes Gutenberg University
Mainz

Locations

Mainz, Germany
Berlin, Germany
Idar-Oberstein, Germany
Martinsried, Germany

Space

111944.67 square feet including
Research and Development, labs,
offices and GMP facilities

Investors

Strüngmann Family Office
MIG Fonds
Salvia GmbH

Affiliates

BioNTech RNA Pharmaceuticals GmbH
BioNTech Diagnostics GmbH
BioNTech Protein Therapeutics GmbH
BioNTech Cell & Gene Therapies GmbH
BioNTech Small Molecules GmbH
JPT Peptide Technologies GmbH
EUFETS GmbH

Core Technologies

mRNA : Immunotherapies
Cell & Gene: TCR /CAR
Protein Therapeutics : Bispecific antibodies;
Microbodies; VLPs

Clinical Programme

8 clinical trials on-going

Partners